Rac-Bifenthrin | CAS 99267-18-2 - Request Quote
Rac-Bifenthrin
| SZ CAT No: | SZ-B122002 |
| CAS No | 99267-18-2 |
| Mol.F. | C23H22ClF3O2 |
| Mol.Wt. | 422.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Usage Note:
Rac-Bifenthrin is chemically (2-Methyl-[1,1'-biphenyl]-3-yl)methyl 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropane-1-carboxylateClC(C(F)(F)F)=CC(C(C)1C)C1C(OCC(C=CC=C2C3=CC=CC=C3)=C2C)=O. Rac-Bifenthrin is supplied with detailed characterization data compliant with regulatory guideline. Rac-Bifenthrin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bifenthrin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 99267-18-2
Purchase 99267-18-2
Order 99267-18-2
Enquire 99267-18-2
price of 99267-18-2
99267-18-2 Supplier
99267-18-2 Manufacturer
99267-18-2 Exporter
buy high quality Rac-Bifenthrin
Purchase Rac-Bifenthrin
Rac-Bifenthrin suppliers
Rac-Bifenthrin manufacturers
Rac-Bifenthrin price
Order Rac-Bifenthrin
Enquire Rac-Bifenthrin
Rac-Bifenthrin cost
Rac-Bifenthrin Supplier
Rac-Bifenthrin Distributor
Rac-Bifenthrin for Method Validation
Bifenthrin Reference Standard
Rac-Bifenthrin for ANDA Filing
Rac-Bifenthrin for Forced Degradation Studies
Rac-Bifenthrin Identification Standards
Rac-Bifenthrin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.